Valuation: AcouSort AB

Market Cap 71.53M 7.4M 6.47M 5.98M 5.5M 10.37M 712M 10.61M 28.09M 349M 27.78M 27.17M 1.21B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 71.53M 7.4M 6.47M 5.98M 5.5M 10.37M 712M 10.61M 28.09M 349M 27.78M 27.17M 1.21B EV / Sales 2026 *
6.75x
EV / Sales 2027 * 4.83x
Free-Float
59.52%
Yield 2026 *
-
Yield 2027 * -
1 day-6.63%
1 week-9.87%
Current month-10.34%
1 month-19.14%
3 months+9.03%
6 months+26.12%
Current year+19.43%
1 week 3.13
Extreme 3.13
3.87
1 month 3.13
Extreme 3.13
4.18
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
28.6
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 01/01/2014
Director of Finance/CFO 65 01/01/2016
Director TitleAgeSince
Director/Board Member 64 01/01/2012
Chairman 65 01/01/2011
Director/Board Member - 01/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
-6.63%-9.87%+6.62%-76.36% 7.42M
-1.29%-3.11%-0.35%+2.64% 49.18B
+3.90%-0.39%+386.06%+588.97% 39.58B
-1.70%+4.46%+5.93%+61.54% 34.69B
-2.01%-0.76%+28.41%-8.52% 34.42B
+0.06%+0.34%+2.38%+34.38% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+72.42%+116.45% 15.36B
+1.12%+1.91%+14.54%+15.44% 14.05B
0.00%+1.36%+18.43%-31.23% 13.02B
Average -0.61%-0.96%+59.38%+78.15% 24.36B
Weighted average by Cap. -0.05%-0.18%+79.44%+122.29%

Financials

2026 *2027 *
Net sales 10.6M 1.1M 959K 887K 815K 1.54M 106M 1.57M 4.16M 51.66M 4.12M 4.03M 180M 14.8M 1.53M 1.34M 1.24M 1.14M 2.15M 147M 2.19M 5.81M 72.13M 5.75M 5.62M 251M
Net income - -
Net Debt - -
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
17/07/26 SEK 3.380 -6.63% 23,675
16/07/26 SEK 3.620 -0.28% 22,083
15/07/26 SEK 3.630 -0.82% 5,645
14/07/26 SEK 3.660 -5.18% 6,991
13/07/26 SEK 3.860 +2.93% 17,273

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACOU Stock